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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYOne major obstacle to the application of stem cell-derived cardiomyocytes (CMs) for disease modeling and clinical therapies is the
inability to identify the developmental stage of these cells without the need for geneticmanipulation or utilization of exogenousmarkers.
In this study, we demonstrate that Raman microspectroscopy can non-invasively identify embryonic stem cell (ESC)-derived chamber-
specific CMs and monitor cell maturation. Using this marker-free approach, Raman peaks were identified for atrial and ventricular CMs,
ESCs were successfully discriminated from their cardiac derivatives, a distinct phenotypic spectrum for ESC-derived CMs was confirmed,
and unique spectral differences between fetal versus adult CMs were detected. The real-time identification and characterization of CMs,
their progenitors, and subpopulations by Ramanmicrospectroscopy strongly correlated to the phenotypical features of these cells. Due to
its high molecular resolution, Raman microspectroscopy offers distinct analytical characterization for differentiating cardiovascular cell
populations.INTRODUCTION
The clinical use of cardiac cells derived from embryonic
and induced pluripotent stem cells (ESCs and iPSCs) is a
promising and potentially patient-tailorable approach to
address myocardial disease. ESCs and iPSCs have an unlim-
ited capacity to self-renew and derive cardiovascular cells
(Burridge et al., 2012; Zwi et al., 2009). However, guiding
pluripotent stem cell differentiation into defined cardiac
cell populations is still a major challenge. In contrast to un-
differentiated ESCs that form tumors in vivo (Amariglio
et al., 2009), cells directed toward the cardiac lineage
in vitro can integrate and support heart function when
delivered in vivo (Leor et al., 2007; Nsair et al., 2012). Cul-
ture protocols for deriving heterogeneous cell populations
that resemble the fetal developmental stages of atrial and
ventricular cardiomyocytes (CMs) from pluripotent stem
cell sources use versatile biological, chemical, and/or phys-
ical factors, and to identify the cardiac differentiation states
requires laborious analytical procedures based on intracel-
lular markers (Mummery et al., 2012; Schenke-Layland
et al., 2008). Patient-specific iPSC-derived CMs offer a
new paradigm for disease-modeling-in-a-dish, as well as
drug screening and discovery (Matsa et al., 2014); however,
it will be imperative to monitor chamber specificity and188 Stem Cell Reports j Vol. 6 j 188–199 j February 9, 2016 j ª2016 The Aumaturity of the pluripotent cell-derived CMs in real time
and preferably marker free. To date, the methods of choice
to determine the developmental stage of differentiating
pluripotent stem cell-derived CMs include invasive gene
and protein expression profiling of harvested cells, or elec-
trophysiological analyses via patch clamp technologies
(Karakikes et al., 2014). Cardiac promoters were used to
drive expression of the fluorescent reporter gene EGFP to
allow identification and sorting of atrial- or ventricular-
like CMs differentiated from pluripotent cell sources
(Huber et al., 2007). However, such genetic manipulation
for the purpose of cell purification is rather laborious, and
most of all, it limits the clinical usability of the cells.
Raman microspectroscopy is a marker-free method that
can be used to characterize single cells based on a pattern
of molecular vibrational modes, which reflects the compo-
sition of intracellular proteins, lipids, nucleic acids, and
carbohydrates (Puppels et al., 1990). Notingher et al.
(2004) investigated changes in Raman spectra due to
cellular differentiation and demonstrated that themethod,
in combination with principal component analysis (PCA),
can be used as a tool for discriminating pluripotent cells
from their cardiac progeny (Pascut et al., 2011). Our group
has integrated a custom-made Raman spectroscopic system
with a fluorescencemicroscope to demonstrate that Ramanthors
signal patterns can be correlated to specific cell phenotypes
and stages (Brauchle et al., 2014). Here, we employed
Raman microspectroscopy to acquire biochemical finger-
prints of the right atrium (RA), right ventricle (RV), left
atrium (LA), and left ventricle (LV) of murine and human
heart tissues. We further assessed biochemical shifts spe-
cific for cardiovascular lineage commitment and cardiac
specification in differentiating murine and human ESCs
(mESCs and hESCs) employing PCA on the spectral
data (Figure S1). The unique combination of Raman spec-
troscopy with high-resolution fluorescence microscopy
allowed the collection of Raman profiles of mESC- and
hESC-derived CMs with an atrial or ventricular specifica-
tion. Raman patterns and spectral differences were verified
by analyzing fetal murine (mfCMs) and human CMs
(hfCMs). We further identified that alterations of cardiac
protein expression patterns, which occur after birth when
CMs adapt to their specific physiological tasks (Sylva
et al., 2014), also correlate to specific shifts in the cardiac
Raman signature and thus Raman microspectroscopy was
used to assess the maturity of the in vitro-generated ESC-
derived CMs.RESULTS
Heart Tissue Exhibits Atria- and Ventricle-Specific
Raman Profiles
The difference in the thickness of the atrial and ventricular
myocardium is a well-described histoanatomical feature,
which reflects the amount of force each chamber is
required to generate in order to pump the blood out of
the adult heart (Figure 1Aa). Although both atria are
much thinner than the ventricles, expression of contractile
proteins such as sarcomeric myosin (MF20) and cardiac
troponin (cTNT) is found equally in the CMs of all heart
chambers (Figures 1Ab and 1Ac). Raman microspectro-
scopy was employed to explore molecular patterns in the
different anatomical sites of the myocardium (LA, RA, RV,
and LV) utilizing formalin-fixed paraffin-embedded (FFPE)
hearts of adult (8months old)mice. Althoughwe identified
that FFPE processing may impact lipid Raman signals (Fig-
ure S2A), our data showed that the Raman spectra specific
for LA and RA, as well as RV and LV, were predominantly
assignable to signals fromproteins (Figure 1Ad andTable 1),
which were unaltered due to tissue processing. By employ-
ing PCA, spectral differences that determine the separation
of atria and ventricles were depicted in principal compo-
nent 2 (PC 2) (Figures 1Ae and S2B). The further analysis
of PC 2 loadings confirmed that Raman signals at 938,
1003, 1342 cm1 and the amide I signal at 1658 cm1
were indeed stronger in the atria compared to the ventricles
(Figure 1Ad), indicating a highly distinct protein contentStem Ceand structure in the atrial versus the ventricular myocar-
dium (Table 1).
Both atria and ventricles septate during early develop-
ment and adapt their specific physiological function (Sylva
et al., 2014). To investigate if the identified spectral differ-
encesmay be impacted by the developmental stages, we re-
corded chamber-specific Raman profiles in murine fetal
hearts at stage E15.5. Anatomically, fetal hearts exhibit
rather large atria and two morphologically similar ventri-
cles, where the compact myocardium of the LV is slightly
thicker than that of the RV (Figure 1Ba). Immunofluores-
cence staining confirmed the expression and alignment
of sarcomeric proteins in both atria (Figure 1Bb) and ventri-
cles (Figure 1Bc) at this stage. In contrast to the Raman
spectra obtained from adult hearts, the signals that were
collected from fetal murine heart tissues were noisier and
more heterogeneous in their peak patterns (Figure 1Bd).
Due to these spectral characteristics, significant differences
between murine fetal atria and ventricles were described in
higher PCs. Themost significant differenceswere identified
in scores of PC 5 and PC 7 (Table S1). By plotting the score
values of PC 5 and PC 7, Raman spectra separated in two
clusters: one cluster included the spectra from both atria
and a second cluster was formed by the spectra from LV
and RV (Figure 1Be). Based on the PC 7 loading, the Raman
peaks at 1003 and 1342 cm1, which represent structural
protein shifts (Table 1), were identified to have a high
impact on the differentiation between murine fetal atria
and ventricles (Figures 1Bd and S2C).
In human hearts from the corresponding developmental
stage of 8–10 weeks after gestation (Sylva et al., 2014), a
strong LV, much thicker than the RV, was observed (Fig-
ure 2A). As expected, LA and RA were much smaller
compared to the ventricles (Figure 2A). Although myofi-
brillar proteins were present and aligned in the atria and
ventricles (Figures 2B and 2C), Raman spectra of LA, RA,
RV, and LV from human fetal FFPE heart tissues showed a
high amount of spectral noise and strong spectral varia-
tions when comparing the different heart chambers (Fig-
ure 2D), similar to what was observed in the mouse tissues.
PCA helped to reduce the spectral noise, and score values
supported the identification of significant differences in
the spectra of FFPE heart tissues. Molecular information
specific for either atria or ventricles was identified in PC 5
(Table S1). Separate clusters for human fetal atrial and ven-
tricular tissues were identified when plotting PC 5 score
values (Figure 2E). The PC 5 loading indicated a high
impact of the Raman peaks at 1003, 1358, 1387, 1426,
1486 cm1 on this separation (Figure S2C). These molecu-
lar differences between human fetal atria and ventricles
can be attributed to vibrationalmodes of proteins (Table 1).
Overall, the multivariate analysis of Raman signals from
FFPE heart tissues revealed molecular differences in thell Reports j Vol. 6 j 188–199 j February 9, 2016 j ª2016 The Authors 189
Figure 1. Identification of Atrial and
Ventricular Raman Signatures in Sections
of Murine Adult and Fetal Hearts
H&E staining of an (Aa) adult and (Ba) fetal
heart displays the four chambers (LA, left
atrium; LV, left ventricle; RA, right atrium;
RV, right ventricle). MF20 (green) and cTNT
(red) are expressed in (Ab, Bb) atria and
(Ac, Bc) ventricles. Nuclei are stained with
DAPI (blue). Scale bars equal 20 mm.
(d) Raman spectra acquired from the LA, RA,
RV, and LV in (Ad) adult and (Bd) fetal heart
tissues. Both adult and fetal atria show
significantly higher relative intensities at
the Raman shift 1342 cm1. (e) Multivariate
analysis of the Raman spectra depicts the
differences between atria and ventricles via
(Ae) PC 2 in adult hearts, respectively (Be)
PC 7 in fetal hearts. See also Figures S2B,
S2C, and S3.atria and ventricles (Figures 1Ac, 1Bc, 2C, and S2C). In
mouse and human hearts, the Raman spectra showed a
clear separation of atria and ventricles due to structural pro-
tein modes. To further investigate if these Raman signals
arose from theCMs in the right and left atria and ventricles,
we explored Ramanprofiles obtained fromprimary isolated
CMs frommurine adult atria and ventricles. Based on PCA,
it was corroborated that spectral differences assigned to190 Stem Cell Reports j Vol. 6 j 188–199 j February 9, 2016 j ª2016 The Auprotein conformational modes allow for the discrimina-
tion of both atrial and ventricular CMs at the single-cell
level (Figures S3A and S3B). However, besides CMs, cardiac
fibroblasts are an abundant cell population in the fetal and
adult heart (Sylva et al., 2014). Since fibroblasts represent a
common contaminant when isolating CMs from primary
tissues or stem cell cultures, it is of high interest to distin-
guish between CMs and fibroblasts in a label-free mannerthors
Table 1. Annotations of Raman Peaks Identified in Chamber
Specificity and Cardiac Fate Commitment
Raman Shift
(cm1) Assignment References
486 glycogen Pascut et al., 2011;
Chan et al., 2009
701 cholesterol Krafft et al., 2005
770–830 nucleic acids Puppels et al., 1990;
Tan et al., 2012
938 proteins in alpha-helix
conformation, troponin T,
myosin, tropomyosin
Pascut et al., 2011;
Pe´zolet et al., 1988
988 proteins in beta-sheet
conformation
Pe´zolet et al., 1988
1003 phenylalanine Puppels et al., 1990
1065 cholesterol Krafft et al., 2005
1095 phosphate backbone of
nucleic acids
Tan et al., 2012;
Pe´zolet et al., 1988
1230–1360 amide III, troponin T,
myosin, tropomyosin
Pascut et al., 2011;
Pe´zolet et al., 1988
1380–1490 CH, CH2, CH3 vibrations
NH in plane vibrations
Krafft et al., 2005;
Pe´zolet et al., 1988
1640–1680 amide I, troponin T, myosin Pascut et al., 2011;
Pe´zolet et al., 1988(Nunes et al., 2013; Sylva et al., 2014). In contrast to cardiac
fibroblasts, CMs express sarcomeric proteins, which
contribute to the unique spectral CM fingerprint (Figures
S3C, S3E, and Table 1). Moreover, PCA showed a clear
distinction between cardiac fibroblasts and CMs based on
the spectral patterns, and therefore encourages the possi-
bility of spectra-based identification and separation of mu-
rine and human CMs (Figures S3D and S3F).
Raman Microspectroscopy as a Tool for Marker-free
Monitoring of Pluripotent Stem Cell Differentiation
toward the Cardiac Cell Lineage
To monitor cardiac cell fate commitment, mESCs and
hESCs were differentiated toward the cardiac cell lineage
following established protocols (Kattman et al., 2011;
Schenke-Layland et al., 2008). According to these previous
reports (Kattman et al., 2011; Schenke-Layland et al.,
2008), embryoid body (EB) formation and induction of dif-
ferentiation resulted in downregulation of pluripotency
genes and upregulation of the expression of lineage-spe-
cific proteins (Figures 3A and S4A). FLK1-expressing pre-
cardiacmesodermwas observed inmurine EB cultures after
6 days of differentiation (Figure 3A). At this stage, murine
cardiovascular progenitor cells (CPCs) were isolated andStem Cepurified using magnetic bead sorting prior to the Raman
measurements (Figure S4B). The expression of cTNT after
10 more days in culture indicated progression of cardiac
differentiation (Figure 3A). Spontaneously beating mESC-
CMs were harvested from murine EB cultures after 18–
21 days of differentiation, which were then immediately
exposed to Raman spectroscopic analyses in suspension
(Video S1). Raman spectra clearly identified different
molecular profiles formESCs,mCPCs, andmESC-CMs (Fig-
ure S4C). PC scores of spectra from single cells were sub-
jected to statistical analyses (Table S2). By plotting PC 3
versus PC 7 scores, a transition from mESCs to mCPCs
and mESC-CMs was evident (Figure 3B). When analyzing
the PC 3 loading, Raman shifts at 701, 784, 1065, 1320,
and 1437 cm1 were determined to indicate cardiac
commitment and differentiation (Figure 3C). To investi-
gate if these Raman signatures could be used in a predictive
manner for the identification of cardiac cells within hetero-
geneous cultures, a PCA-linear discriminant analysis (LDA)
was employed on the datasets (Chan et al., 2009). When
applying testing data on this PCA-LDA model, 95% of the
spectra from mESCs were categorized as such; the sensi-
tivity for discriminatingmCPCs andmCMswas 44% (Table
S3). These results were consistent with the plot of the PCA
scores, where the clusters of mCPCs and mESC-CMs over-
lapped (Figure 3B).
In cultures of human EBs, stage-specific growth factors
guided cardiac differentiation, which was evident after
10 days of differentiation, when spontaneous beating of
EBs was observed (Video S2). Moreover, at this time point,
the expression of cTNT, MF20, and CX43 confirmed car-
diac differentiation (Figures 3D and S5A). In terms of cell
morphology and cTNT expression patterns, hESC-CMs
were highly comparable with hfCMs (Figure 3D and Video
S3).When subjecting the Raman spectra acquired for single
hESCs, hESC-CMs, and hfCMs to PCA,most significant dif-
ferences were observed between hESCs and hfCMs in PC 1,
whichwere assignable to glycogen (Figure S5B and Table 1).
Similarities of hESC-CMs and hfCMs were evident in PC 4
score values (Table S2). Plotting PC 1 versus PC 4 scores
separated the spectra of hESCs from hfCMs and indicated
successive spectral shifts due to the progression of cardiac
differentiation (Figure 3E). We identified wavenumbers
486, 701, 784, 1003, 1065, 1320, and 1437 cm1 as pre-
dominantly affected during human cardiac differentiation
(Figure 3F). These signals suggest a decrease in nucleic acids
and an increase of lipids and cholesterol due to cardiac dif-
ferentiation (Table 1). Most interestingly, many analogous
Raman peaks were identified in the analysis of Raman
spectra from murine cells (Figures 3C and 3F), which sug-
gests that these cellular components might have a spe-
cies-independent key role in cardiac cell fate commitment
and differentiation.Moreover, our results demonstrate thatll Reports j Vol. 6 j 188–199 j February 9, 2016 j ª2016 The Authors 191
Figure 2. Molecular Differences in Atria
and Ventricles of the Human Fetal Heart
(A–C) H&E staining displays the four heart
chambers in the human fetal heart (A). LA,
left atrium; LV, left ventricle; RA, right
atrium; RV, right ventricle. Immunofluores-
cence staining (MF20, green; cTNT, red) of
the (B) atria and (C) ventricles. DAPI (blue)
shows cell nuclei. Scale bars represent
20 mm.
(D) Raman spectra collected from LA, RA, RV,
LV detected in human fetal heart sections.
Differences between atria and ventricles
were identified at the wavenumbers 1003,
1358, 1387, 1423, 1486 cm1.
(E) PCA depicting distinct populations for
spectra collected from atria (red) and ven-
tricles (blue). See also Figures S2D and S3.Raman spectra and PCA are potentially capable of support-
ing marker-free identification of stem cell-derived cardiac
cells within heterogeneous cultures.
Raman Profiles Identify Chamber-SpecificMurine and
Human ESC-CMs
The commitment of CMs to atrial or ventricular pheno-
types occurs early in development during linear heart
tube formation and can also be observed in stem cell-
derived CMs (Mummery et al., 2012). Based on the expres-
sion of myosin light chain 2 (MLC2) isoforms, atrial and
ventricular CMs can be distinguished (Mummery et al.,
2012). This distinction of atrial and ventricular CMs is
important when stem cell-derived cells are to be considered
for disease modeling, drug screening and discovery, and for
clinical regenerative therapies. High-resolution fluores-
cence imaging was performed simultaneously to Raman
spectra acquisition to investigate whether Raman micro-
spectroscopy can identify atrial and ventricular CMpheno-
types derived from pluripotent stem cells (Brauchle et al.,
2014). For this purpose, all murine and human cells were
fixed and stained for MLC2a (atrial isoform of MLC2) and
MLC2v (ventricular isoform of MLC2). In addition to
ESC-CMs, we processed fetal CMs in the same fashion for
verification of the Raman patterns from MLC2a+ and
MLC2v+ CMs (Figures 4 and 5).
Although both mfCMs and mESC-CMs maintained
MLC2a orMLC2v expression after cell isolation and attach-
ment, the structural organization of both proteins lacked
distinctive striated myofibrillar patterns (Figures 4A, 4B,192 Stem Cell Reports j Vol. 6 j 188–199 j February 9, 2016 j ª2016 The Au4E, 4F, and S4D). Raman spectra were collected from freshly
isolated and antibody-labeled MLC2a+ and MLC2v+
mfCMs and mESC-CMs in suspension (Figures 4C and
4G). Plotting of the PC scores of the Raman spectra from
MLC2a+ and MLC2v+ mfCMs revealed two clearly sepa-
rated populations (Figure 4D and Table S4). The PC 3
loading highlighted the wavenumbers 1265, 1336, 1386,
1660 cm1 as having a great influence on this separation
of atrial and ventricular mfCMs (Figure S2E). Our data
showed that MLC2a+ mfCMs exhibited stronger signals
in 1265 and 1660 cm1, whereas in Raman spectra from
MLC2v+ mfCMs, signals at 1336 and 1386 cm1 were
more pronounced (Figure 4C). PCA of the vibrational sig-
nals of single MLC2a+ and MLC2v+ mESC-CMs also
showed two distinct populations (Figure 4H). The spectral
shifts that indicate atrial and ventricular commitment
emerged in PC 3 and PC 4 (Figure 4H and Table S4). Based
on the PC 4 loading pattern, the Raman peaks at 1336 and
1670 cm1 were identified to have a strong impact on
spectra of MLC2a+ mESC-CMs, whereas the influence of
vibrational signals at Raman shifts 1408 and 1437 cm1
was more pronounced in MLC2v+ mESC-CMs. Further-
more, the Raman signals at 786 and 1095 cm1 had an
effect on the PCA-based distinction of MLC2a+ versus
MLC2v+ mESC-CMs and were more prominent in the
spectra of MLC2a+ mESC-CMs (Figures 4G and S2G).
Our results showed that mouse atrial CMs differ from
ventricular CMs in the amide I peak, which is indicative
for protein conformational modes in MLC2a+ mfCMs
compared toMLC2v+ mfCMs (Table 1). In hfCMs, isolatedthors
Figure 3. Differentiation of Mouse and
Human Embryonic Stem Cells Toward
Cardiomyocytes Monitored by Immuno-
fluorescence Staining and Raman Micro-
spectroscopy
(A) Bright field (a, c, e) and immunofluo-
rescence microscopy (b, d, f) of mESCs
and embryoid bodies containing cardiovas-
cular progenitor cells (CPCs) (c, d), and
cardiac troponin T (cTNT)-positive mESC-
derived cardiomyocytes (ESC-CMs). Scale
bars equal 200 mm (a, c, e) and 50 mm (b, d,
e).
(B) Scores of principal component (PC) 3
and PC 7 for Raman spectra of mESCs, mCPCs,
and mESC-CMs. The arrow indicates cardiac
differentiation.
(C) PC 3 loading presents the Raman peaks
that change significantly due to cardiac
commitment and differentiation.
(D) Morphology of (a) hESC colonies, (c)
hESC-CMs, and (e) human fetal CMs (hfCMs).
Scale bars equal 200 mm. Fluorescence mi-
croscopy of Oct4 staining on (b) hESCs and
cTNT staining of (d) hESC-CMs and (f) fhCMs.
Scale bars represent 20 mm.
(E) Scores of PC 1 and PC 4 of Raman spectra
from hESCs, hESC-CMs, and hfCMs demon-
strate successive spectral changes due to
cardiac differentiation highlighted by the
arrow.
(F) Raman peaks with successive change
from hESCs to hESC-CMs and hfCMs are
illustrated by loading of PC 4. Peaks that are
consistent with the murine pattern in (C)
are indicated. See also Figures S4 and S5.from 8- to 9-week-old hearts, the expression ofMLC2a and
MLC2v was determined after cell isolation and attach-
ment (Figures 5A and 5B). Raman spectra specifically
generated from MLC2a+ and MLC2v+ hfCMs exhibited a
high SD resembling the high heterogeneity of these cell
populations (Figure 5C). When analyzing these spectra
with PCA, significant differences (p < 0.05) between
MLC2a+ and MLC2v+ hfCMs were identified in the PC 3
scores (Table S4). The PC scores plot, including PC 2 and
PC 4, depicted two cell populations for MLC2a+ and
MLC2v+ hfCMs but also an intermediate zone where
both populations overlapped (Figure 5D). For the spectralStem Cedistinction ofMLC2a+ andMLC2v+ hfCMs, thewavenum-
bers 1096, 1320, 1336, 1375, and 1423 cm1 had a high
impact on the separation of MLC2a+ and MLC2v+ hfCMs
(Figure 5C and S2F). Interestingly, MLC2a expression in
hESC-CMs showed an organized myofibrillar structure
and alignment (Figure 5E), whereas MLC2v expression
was rather low andwas detected in significantly fewer cells
compared with MLC2a+ hESC-CMs (Figures 5F and S5C).
Despite these differences in protein expression, Raman
spectra acquired from MLC2a+ and MLC2v+ hESC-CMs
showed congruence with lower SDs compared to the pri-
mary isolated fetal cells (Figure 5G). In depth PCA revealedll Reports j Vol. 6 j 188–199 j February 9, 2016 j ª2016 The Authors 193
Figure 4. Identification of Atrial and
Ventricular Specification in Murine Fetal
Cardiomyocytes and Murine Embryonic
Stem Cell-Derived Cardiomyocytes
(A and B) Fluorescence microscopy of mfCMs
isolated from the atria and stained for (A)
MLC2a and (B) mfCMs that were isolated
from the ventricles identified by MLC2v
expression.
(C) Based on MLC2a and MLC2v expression,
atrial and ventricular mfCMs were identified
and Raman microspectroscopy was per-
formed on the single antibody-labeled cells.
Vertical lines highlight wavenumbers iden-
tified in the principal components (PCs).
(D) Scores plot of the spectra depicts dif-
ferentiation of MLC2a+ and MLC2v+ mfCMs
via PC 1, 2, and 3. mESC-CMs stained for (E)
MLC2a and (F) MLC2v to detect atrial and
ventricular specification. Scale bar repre-
sents 20 mm.
(G) Raman spectra recorded fromMLC2a+ and
MLC2v+ mESC-CMs, highlighting the wave-
numbers of the most prominent differences.
(H) PC scores plot visualizes two clusters
based on the spectra. See also Figures S2E
and S2G.significant differences in Raman spectra in PC 3 and PC 4
scores from MLC2a+ and MLC2v+ hESC-CMs (Figure 5H
and Table S4). Two separated hESC-CM populations were
visualized in the PCA scores plot, although few MLC2a+
hESC-CMs clustered with MLC2v+ hESC-CMs and vice
versa (Figure 5H). The closer investigation of the PC 4
loading pattern elucidated a stronger influence of the
Raman peaks at 788, 1336, 1362, and 1380 cm1 on the
spectra from MLC2v+ hESC-CMs compared with those
from MLC2a+ hESC-CMs (Figure S2H). Furthermore, PC
4 depicted a shift in the spectra of MLC2v+ hESC-CMs in
the amide I region around 1658 cm1 (Figures 5G and
S2H). Similar to the PCA-based separation of hfCMs, we
identified overlaps between the clusters of MLC2a+
hESC-CMs with those of MLC2v+ hESC-CMs (Figure 5H).
Additional immunofluorescence staining of human fetal
heart tissues visualized ventricular CMs co-expressing
both proteins (Figure S5D). The presence of double-posi-
tive MLC2a+/MLC2v+ CMs might explain the overlap of
both CM subtypes in the PCA scores plot (Figure 5D),
where both MLC2a or MLC2v expression was considered
in single cells.
Raman Microspectroscopy Allows the Label-free
Monitoring of Cardiac Maturation
For in vitro drug screening, CMs must exhibit a mature
fully functional cardiac phenotype in order to mimic194 Stem Cell Reports j Vol. 6 j 188–199 j February 9, 2016 j ª2016 The Aunormal cardiac physiology (Matsa et al., 2014). However,
CMs derived from pluripotent stem cell sources using
standard differentiation protocols resemble an imma-
ture fetal phenotype (Matsa et al., 2014). As expected
when using standard cardiac in vitro differentiation
protocols, in our study, mESC-CMs showed incomplete
alignment and insufficient sarcomeric myosin striation
(Figure 6Ab). In vivo, CMs undergo substantial meta-
bolic and structural evolution after birth (Pasumarthi
and Field, 2002; Siedner et al., 2003), resulting in
morphological changes as well as an increase in the
expression level of myofibrillar proteins (Figure 6Af). In
correlation with these known features, Raman spectra
of mESC-CMs and mfCMs showed clear differences
compared with the spectra of murine adult CMs (Fig-
ure S6A). PCA confirmed this result and further revealed
that the significant differences were identified in the PC
3 and PC 4 score values (Figure 6B and Table S5). The
PC 3 loading spectrum highlights that Raman signals at
1266, 1437, and 1658 cm1, which indicate proteins
and lipids, increased due to the postnatal maturation of
CMs (Figure 6C and Table 1). Nucleic acid-specific modes
at 787 and 1095 cm1 decreased, and were more pro-
nounced in mESC-CMs and mfCMs (Table 1). Interest-
ingly, these differences in the Raman spectra were also
observed in fetal versus adult FFPE tissues (Figures S6B
and S6C).thors
Figure 5. Characterization of Atrial and
Ventricular Phenotypes in Human Fetal
Cardiomyocytes and Human Embryonic
Stem Cell-Derived Cardiomyocytes
(A and B) Detection of atrial and ventricular
fhCMs via (A) MLC2a and (B) MLC2v staining.
Scale bar equals 20 mm.
(C and D) Raman spectra and data analysis of
MLC2a+ and MLC2v+ fhCMs.
(D) Scores plot of the spectra depicts dif-
ferentiation of MLC2a+ and MLC2v+ mfCMs
via PC 2, 3, and 4. Atrial and ventricular
specification of hESC-CMs detected by (E)
MLC2a and (F) MLC2v expression.
(G) Raman microspectroscopy of MLC2a+ and
MLC2v+ hESC-CMs.
(H) PC scores plot visualizes a distinction
between MLC2a+ and MLC2v+ CMs based on
Raman data. See also Figures S2D and S2F.DISCUSSION
This study demonstrates the power of Raman microspec-
troscopy as an optical marker-free technology to assess car-
diovascular commitment, cardiac differentiation, and
cardiac maturation in primary isolated cells and tissues,
as well as cells and tissue equivalents (EBs) derived
from pluripotent stem cell sources. Species-independent
changes due to cardiovascular cell fate commitment and
differentiation were identified based on Raman profiles ac-
quired from murine and human cells. Phenotype-specific
cardiac signals, which can be used to differentiate between
atrial and ventricular CMs that are derived from pluripo-
tent stem cells, were identified using multivariate analysis.
Moreover, we showed that Raman microspectroscopy is a
suitable tool to assess cardiac maturity in living single
CMs as well as cardiac tissues. To date, no other modality
has non-invasively demonstrated such clear specification
of stem cell-differentiated CMs based on chamber and
developmental stage.
Nevertheless, technological improvements and adap-
tions will be necessary to achieve the transition of Raman
microspectroscopy from a tool for research and develop-
ment purposes to a routine device for the marker-free
single-cell sorting and high-throughput analysis. In a
very elegant study, Dochow et al. (2013) showed the feasi-
bility of Raman spectroscopy and cell sorting in amicroflui-
dic chamber. The further reduction of measurement times
and the establishment of automated software to facilitateStem Cespectral analysis, and for non-experienced users, are
currently addressed by other groups (Ren et al., 2014;
Richardson et al., 2014).
Our microspectroscopic approach shows that mESCs,
hESCs, and their cardiac progeny exhibit uniquemolecular
fingerprints, and the acquisition of Raman spectral data
from such biological materials provides insights into mo-
lecular and developmental cell biology processes, poten-
tially enabling the identification of molecular drivers in
cell differentiation pathways (Sule-Suso et al., 2014). The
Raman spectra obtained from ESCs were consistent with
data published by others (Chan et al., 2009). As previously
described, mESC molecular fingerprint patterns showed
characteristic signals that can be attributed to nucleic acids
(Notingher et al., 2004). Here, we detected onlymedian nu-
cleic acid peaks, but stronger signals from lipids at 1300,
1437, and 1658 cm1 (Krafft et al., 2005) in hESCs. Culture
conditions as well as cell line-specific variations, which are
controversially discussed for pluripotent stem cells (Bur-
ridge et al., 2012), could impact the molecular Raman
signature. Tan et al. (2012) showed that differences in the
spectra of hESCs and hiPSCs are only minimal compared
with the spectral shifts that occur due to cell differentia-
tion. This is consistent with our data presented in this
study, where cardiac differentiation led to specific molecu-
lar changes in the cellular fingerprint spectrum of pluripo-
tent cells. Namely, cardiac cell fate commitment was
detectable by an increase of the Raman bands at 701,
1065, and 1437 cm1 in human and murine cells. Thesell Reports j Vol. 6 j 188–199 j February 9, 2016 j ª2016 The Authors 195
Figure 6. Comparison of Murine Embry-
onic Stem Cell-Derived CMs, Murine Fetal
CMs, and Murine Adult CMs
(A) mESC-derived EB (a), fetal (c), and adult
hearts (e) before cell isolation, and sarco-
meric myosin (MF20, green) expression
patterns in mESC-CMs (b), mfCMs (d), and
maCMs (f). Scale bars represent 1 mm
(a, c, e) and 20 mm (b, d, f).
(B) Plot of PC 3 and PC 4 score values derived
from Raman spectra of mESC-CMs, mfCMs,
and maCMs indicate maturation from a fetal
to an adult CM phenotype (indicated by the
direction of the gray arrow).
(C) PC 3 loading describes the Raman shifts
that vary in mature maCMs compared to
mESC-CMs and mfCMs. See also Figure S6.Raman bands can be assigned to cholesterol but also other
lipid molecules (Krafft et al., 2005). Although it has been
described that lipids play a role in energy storage and ho-
meostasis in cardiac muscle, the role of lipid metabolism
and energy storage in cardiac cell fate decisions has not
been fully understood. The metabolic machinery of ESCs,
in contrast to ESC-CMs, is reported to be only rudimen-
tarily developed (Chung et al., 2007). In cardiac differenti-
ation, successive remodeling of this metabolic system has
been identified to orchestrate the alignment of mitochon-
dria and cardiac-specific key regulators for high energy-
dependent CMs (Chung et al., 2007). Cholesterol-rich
membrane domains, cholesterol signaling, and lipid meta-
bolism might play a role in early cardiac cell fate decisions
as the Raman profiles of ESCs, CPCs, and ESC-CMs vary
significantly. To our knowledge, this is the first report in
which Raman microspectroscopy was employed for CPC
characterization. To further elucidate CPC subpopulations,
the spectroscopic data could be correlated with data of
cellular metabolism and protein expression to subspeciate
this heterogeneous population.
ESC-CMs can be subdivided into atrial and ventricular
CMs (Burridge et al., 2012). It has been documented that
the expression of the a-isoform of myosin heavy chain
(a-MHC), MLC2a, and MLC1a become restricted to the
atrium during murine development (Zammit et al., 2000).
Here, we employed MLC2a and MLC2v immunocytologi-
cal staining to identify murine and human CM subtypes
and demonstrated that Raman microspectroscopy can
identify atrial and ventricular CM subpopulations derived196 Stem Cell Reports j Vol. 6 j 188–199 j February 9, 2016 j ª2016 The Aufrom pluripotent murine and human cells. Atrial and ven-
tricular CMs exhibit differences in the expression and orga-
nization of structural proteins (Bird et al., 2003; Zammit
et al., 2000). We identified structural protein signals (938,
1265, 1658 cm1) as highly relevant for the spectral-based
differentiation of atrial and ventricular CMs. Muscle fibers,
including myosin proteins, contain predominantly alpha-
helical conformations, which can be identified using wave-
numbers at 938 and 1660 cm1 (Pe´zolet et al., 1988). These
signals are consistent with those identified in purified
myosin and tropomyosin (Pascut et al., 2011; Pe´zolet
et al., 1988). The spectral area of 1380–1490 cm1 was
more prominent in ventricular CMs than in atrial CMs.
Pascut et al. (2011) showed that this area exhibits specific
signals that can be used to discriminate CMs from non-
CMs. The wavenumber region of 1380–1490 cm1 refers
to CH2 and CH3 vibrations and could signify differences
in the organization of intracellular proteins (Table 1). In
murine fetal development, it was demonstrated that
atrial-ventricular specification is initiated before E15.5 at
the fetal stage (Zammit et al., 2000). However, less is known
about these developmental stages in human heart develop-
ment. Notably, the Raman data we recorded from human
fetal heart tissues and human cardiac cells attest a higher
complexity than in the respective data from murine cells.
Previously, MLC2a and MLC2v double-positive CMs were
derived from hESC cultures (Mummery et al., 2012), which
are also seen during normal human heart development.
These CM subpopulations, which are not yet fully
committed to an atrial or ventricular fate, were also notedthors
in our study. In future studies, Raman microspectroscopy
could be further correlated to gene and protein marker
expression profiles and functional measurements of these
CM subpopulations. The technology could thereby help
to resolve early cell fate decisions made on the path toward
atrial and ventricular cardiac phenotypes (Sylva et al.,
2014).
By characterizing ESC-CMs, fetal CMs, and murine adult
CMs using Ramanmicrospectroscopy, we confirmed a fetal
cardiac cell phenotype profile of ESC-CMs, which is in
accordance with investigations in which comparable
gene expression profiles of ESC-CMs and fetal CMs were re-
ported (Cao et al., 2008).We further showed that lipid- and
protein-related Raman bands at 1266 cm1, 1437 cm1,
1658 cm1 were more prominent in adult CMs than in
ESC-CMs or fetal CMs. Immunofluorescence staining
confirmed the presence of densely packed sarcomeric
myosin in adult CMs versusmore diffusely organized sarco-
meric structures with shorter fragments in fetal CMs,
which could be the possible reason for the spectroscopic
differences that were detected in our study. Different stages
of sarcomeric organization and increasing myofibril den-
sities were also seen when employing standard methods
in developing CMs (Pohjoismaki et al., 2013). In adult
CMs, a lower nuclear density, higher mitochondrial den-
sity, and a metabolic shift toward b-oxidation of fatty acids
was previously reported (Pohjoismaki et al., 2013). In addi-
tion, it was shown that fetal and adult CMs express differ-
ential isoforms of troponin C (Siedner et al., 2003), which
might also have an impact on protein-related Raman sig-
nals at wavenumbers 1266 and 1658 cm1. Many features
that are characteristic for fetal cardiac phenotypes have
been described in stressed and pathological CMs (Gilsbach
et al., 2014). Relapse of the MHC-isoform shift and the
downregulation of fatty acid oxidation were reported as
hallmarks of heart failure (Rajabi et al., 2007). Our results
suggest that Raman microspectroscopy could potentially
detect pathological CMs and therefore represents a very
promising tool for the monitoring and diagnosis of patho-
logical or stress-induced remodeling processes in the heart.
To summarize, in this study we demonstrated that
Raman microspectroscopy can be used for the marker-free
identification and characterization of different cardiac
cell phenotypes and subpopulations. This technique en-
ables the determination of the optimal endpoint in cardiac
differentiation processes and facilitates a standardized
characterization of in vitro-generated cardiac cells and tis-
sues toward the goal of a clinical application.EXPERIMENTAL PROCEDURES
Detailed information on the experimental procedures can be
found in the Supplemental Information File.Stem CeRaman Microspectroscopy
All Raman spectra were recorded using a custom-built Raman mi-
crospectrometer as previously described (Brauchle et al., 2014).
For all measurements, the laser power was maintained at 85 mW
and the total accumulation time per spectrum was 100 s. Spectra
were acquired from single living or fixed and antibody-labeled cells
in suspension with medium or buffer in glass-bottom dishes
(ibidi). For antibody-labeled cells, fluorescence microscopy was
employed simultaneously with the Raman measurements to cate-
gorize cells according to their staining patterns. To discriminate
single hESCs from their feeder layer, cells were stained for Tra-1-
81 (mouse IgM conjugated to Alexa Fluor 488; Biolegend) without
fixation (see Supplemental Information for details). For the identi-
fication of atrial and ventricular CMs, cells were fixed and labeled
using MLC2a-FITC and MLC2v-PE (both Miltenyi Biotech; see
Supplemental Information for details). FFPE tissues were de-paraf-
finized, rehydrated, and kept hydrated in medium or PBS buffer
during the measurements. A background reference spectrum of
the glass surface was taken every 5–10 spectra by measuring a
cell-free and particle-free area.
Processing and Multivariate Analysis of Raman
Spectra
Several mathematical processes were employed on the spectro-
scopic raw data to diminish background effects and to correct
instrumental variations. For all spectra, background signals were
subtracted, cosmic rays were removed, the spectral window was
confined to the range of 400–1800 cm1, and baseline shifts
were adjusted (OPUS-Software 4.2; Bruker Optics). Vector normal-
ization was performed to assimilate all spectra in their overall
signal intensity level, which are presented in arbitrary units. To
increase the signal to noise ratio in the Raman spectra of histo-
logically processed and fixed specimens, 11 data points were aver-
aged by employing a second ordered Savitzky-Golay filtering
(UnscramblerX 10.2; CAMO). PCA, which focuses on the spectral
range of 400–1800 cm1, was calculated frompretreated spectra us-
ing the NIPALS algorithm (UnscramblerX 10.2). In an optimized
set-up, PCA extracts valuable differences from spectral noise and
random variations. In each PCA, seven principal components
(PCs) were considered. All PCs were considered in the results, since
even higher PCs, which cover fewer percentages of the overall var-
iances, exhibited loading patterns with prominent biochemical
signals. PC score values were further subjected to statistical anal-
ysis, which was performed using OriginPro 9.0.0G (OriginLab
Corporation). PC scores were verified for normality distribution
using the Kolmogorov-Smirnov test. ANOVA was employed to
calculate probability values (p values) and to identify significant
differences between different cell populations based on PC score
values. As a model for data prediction, a discriminate analysis
(LDA) was conducted based on PC scores (Chan et al., 2009).
For two-dimensional scores plots, confidence ellipses, which
comprised the coordinates of each spectrum in the scores plot,
were calculated (95% probability).
Use of Murine and Human Tissues
The Institute of Cellular Biology and Immunology at University of
Stuttgart provided adult hearts of 8-month-old female CD1 micell Reports j Vol. 6 j 188–199 j February 9, 2016 j ª2016 The Authors 197
and fetal mouse hearts. Appropriate surgical explantation of the
murine hearts was performed in accordance with the institutional
guidelines of animal ethics and care of the University of Stuttgart.
Human fetal heart tissues were used in accordance with institu-
tional guidelines and approved by the local research ethics com-
mittees at the University Hospital of the Eberhard Karls University
Tuebingen (UKT) and the University of California Los Angeles
(UCLA) (UKT IRB #356/2008BO2 and #406/2011BO1, UCLA
IRB #05-10-093). The use of human adult heart cells was in accor-
dance with institutional guidelines and approved by the research
ethics committee of the Landesa¨rztekammer Baden-Wu¨rttemberg
(IRB #F-2011-068).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, six figures, five tables, and three videos and can be
found with this article online at http://dx.doi.org/10.1016/j.
stemcr.2015.12.007.
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